This inventor holds 1 USPTO granted patent and 13 published patent applications. Top assignee: Palleon Pharmaceuticals Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Li Peng
Introduction
Li Peng is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human sialidases. His work has the potential to impact cancer treatment significantly.
Latest Patents
Li Peng holds a patent for "Recombinant human sialidases, sialidase fusion proteins, and methods of using the same." This invention relates to recombinant human sialidases and recombinant sialidase fusion proteins, which may contain mutations compared to wild-type human sialidase. The patent also includes antibody conjugates that combine a sialidase with an antibody or a portion thereof. Furthermore, it outlines methods for using these sialidase fusion proteins or antibody conjugates in cancer treatment. He has 1 patent to his name.
Career Highlights
Li Peng is currently associated with Palleon Pharmaceuticals Inc., where he continues to innovate in the field of biotechnology. His research focuses on developing therapeutic solutions that leverage the unique properties of sialidases.
Collaborations
Li has collaborated with notable colleagues, including Lihui Xu and Lizhi Cao, who contribute to the dynamic research environment at Palleon Pharmaceuticals Inc.
Conclusion
Li Peng's work exemplifies the intersection of innovation and biotechnology, showcasing how his inventions can lead to advancements in cancer treatment. His contributions are paving the way for future breakthroughs in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile